A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated) benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.
Listing Vs. Other Funding Sources
Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.
A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies
As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.
Given the federal uncertainty that still surrounds cannabis in America and in most of the world, few cannabis companies choose the path of a public listing in order to raise funds and even fewer among them are pure-play marijuana stocks.
Listing Vs. Other Funding Sources
Listing a stock allows enables fundraising from a larger pool of investors. At the same time, a publicly-traded stock can be volatile, and even more so in an emerging sector like cannabis.
OrganiGram Holdings Inc. (NASDAQ: OGI)Tilray, Inc.
Tilray, Inc. is in the process of merging with Aphria Inc. (NASDAQ: APHA) creating one of the largest revenue producers in the cannabis industry. At the present time, Tilray has a presence across 17 countries on five continents. In February Tilray reported its Q4 and 2020 full fiscal Year financials results. In detail, the companyâs revenue increased 26% to $210.5 million compared to 2019. Also, Tilray cut its net loss to $3 million in Q4 2020 compared to a net loss of $219.8 million in Q4 of 2019. As it stands Tilray is implementing a more focused efficient and competitive cost structure. After the launch in Canada of cannabis 2.0, the company has seen a rise of 26% in the adult-use market.